GRAIL, Inc. (GRAL) reporting calendar
GRAIL, Inc. files periodic reports with the SEC as GRAL on Nasdaq. Atlas tracks 8 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 28 Jul 2026 – 31 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 7 May 2026
- Reports on record
- 8
How this window is derived. Derived from this issuer's own filing history: 8 periods at a median 92-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open GRAL market profile
Latest filing on SEC EDGAR ↗
Services-Medical Laboratories reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 7 May 2026 | 37 days | 0001628280-26-032090 |
| 10-K | 31 Dec 2025 | 12 Mar 2026 | 71 days | 0001628280-26-017319 |
| 10-Q | 30 Sep 2025 | 13 Nov 2025 | 44 days | 0001699031-25-000193 |
| 10-Q | 30 Jun 2025 | 13 Aug 2025 | 44 days | 0001699031-25-000166 |
| 10-Q | 31 Mar 2025 | 14 May 2025 | 44 days | 0001699031-25-000114 |
| 10-K | 31 Dec 2024 | 5 Mar 2025 | 64 days | 0001699031-25-000041 |
| 10-Q | 30 Sep 2024 | 13 Nov 2024 | 44 days | 0001628280-24-047606 |
| 10-Q | 30 Jun 2024 | 13 Aug 2024 | 44 days | 0001628280-24-036965 |
Source: SEC EDGAR company submissions for CIK 0001699031. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.